Portillo's Inc.
PTLO Nasdaq Retail-Eating Places Financials FY2019–FY2025
Last close · Oct 23, 2026
$4.21
6.7%What Portillo's Inc. does
No business description yet.
- Legal name
- Portillo's Inc.
- Fiscal year ends
- December 28, 2025
- Latest annual report
- 10-K · Feb 24, 2026
- Accession · CIK
- 0001871509-26-000012
0001871509
Revenue and margins
Portillo's Inc. had $732M of revenue in fiscal 2025, up 3.0% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was −$18.5M in fiscal 2025, −2.5% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Portillo's Inc. returned — to shareholders in fiscal 2025. The diluted share count rose 11.1%.
Balance sheet
Cash, debt and the ratios that show how comfortably Portillo's Inc. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $39.3M | $44.4M | $10.4M | $22.9M | $20.0M |
| Debt incl. finance leases | $319M | $319M | $321M | $337M | $424M |
| Net debt / EBITDA | 5.2x | 4.4x | 3.9x | 3.7x | 5.6x |
| Debt / equity | 1.9x | 1.2x | 1.0x | 0.8x | 0.9x |
| Interest coverage | 0.8x | 1.5x | 2.0x | 2.3x | 1.9x |
| Current ratio | 0.9x | 0.8x | 0.4x | 0.4x | 0.3x |
| Quick ratio | 0.8x | 0.7x | 0.3x | 0.3x | 0.2x |
| Total assets | $1,000M | $1.3B | $1.4B | $1.5B | $1.6B |
| Total liabilities | $576M | $847M | $925M | $1.0B | $1.1B |
| Shareholders' equity | $171M | $256M | $322M | $401M | $468M |
| Net debt (− = net cash) | $280M | $274M | $311M | $314M | $404M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. “Plan” marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.
| Test | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|
| Net income is positive | ✕ | ✕ | ✕ | ✓ | ✓ | ✓ | ✓ |
| Cash from operations is positive | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Return on assets rose | — | — | ✕ | ✓ | ✓ | ✓ | ✕ |
| Cash from operations exceeds net income | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Debt fell relative to assets | — | — | ✓ | ✓ | ✓ | ✓ | ✕ |
| Current ratio rose | — | — | ✓ | ✕ | ✕ | ✕ | ✕ |
| Share count didn't rise | — | ✕ | ✓ | ✕ | ✕ | ✕ | ✕ |
| Gross margin rose | — | — | — | — | — | — | — |
| Revenue rose relative to assets | — | — | ✓ | ✕ | ✓ | ✕ | ✕ |
| F-score | — / 3 | — / 4 | 6 / 8 | 5 / 8 | 6 / 8 | 5 / 8 | 3 / 8 |
| Accruals ratio | — | −7.3% | −6.1% | −4.0% | −3.9% | −4.7% | −3.4% |
| Altman Z'' | — | 0.60 | 0.41 | 0.46 | 0.37 | 0.41 | 0.17 |
7 years of figures
Amounts in USD. Hover a ratio’s name for its definition.
| Fiscal year | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | $479M | $455M | $535M | $587M | $680M | $711M | $732M |
| Operating income | $48.9M | $57.3M | $30.0M | $41.3M | $55.4M | $58.0M | $43.7M |
| Interest expense | $43.4M | $45.0M | $39.7M | $27.6M | $27.5M | $25.6M | $22.8M |
| Pretax income | $5.6M | $12.3M | −$16.9M | $19.0M | $28.1M | $41.9M | $24.1M |
| Income tax | $0.0M | $0.0M | −$3.5M | $1.8M | $3.2M | $6.8M | $3.0M |
| Net income | −$12.9M | −$8.3M | −$15.2M | $10.9M | $18.4M | $29.5M | $19.3M |
| Diluted EPS | −$0.25 | −$0.16 | −$0.42 | $0.25 | $0.32 | $0.46 | $0.27 |
| Diluted shares | 0.05B | 0.05B | 0.04B | 0.04B | 0.06B | 0.06B | 0.07B |
| Cash flow | |||||||
| Cash from operations | $43.3M | $58.3M | $42.9M | $56.9M | $70.8M | $98.0M | $71.9M |
| Capital expenditure | $22.0M | $21.5M | $36.2M | $47.1M | $87.9M | $88.2M | $90.4M |
| Free cash flow | $21.3M | $36.8M | $6.7M | $9.8M | −$17.1M | $9.8M | −$18.5M |
| Depreciation and amortization | $24.4M | $24.6M | $23.3M | $20.9M | $24.3M | $27.3M | $29.1M |
| Stock-based compensation | $1.3M | $1.0M | $29.4M | $16.1M | $15.5M | $11.2M | $6.5M |
| Balance sheet | |||||||
| Cash and short-term investments | $22.6M | $41.2M | $39.3M | $44.4M | $10.4M | $22.9M | $20.0M |
| Total debt | — | $470M | $319M | $319M | $321M | $337M | $424M |
| Current assets | — | $54.6M | $59.0M | $65.3M | $41.9M | $52.7M | $51.5M |
| Current liabilities | — | $66.4M | $66.9M | $77.3M | $105M | $136M | $194M |
| Inventory | — | $5.1M | $6.1M | $7.4M | $8.7M | $7.9M | $8.2M |
| Property and equipment, net | — | $175M | $191M | $227M | $296M | $359M | $420M |
| Goodwill | — | $394M | $394M | $394M | $394M | $394M | $394M |
| Intangible assets | — | $266M | $260M | $256M | $253M | $250M | $245M |
| Total assets | — | $910M | $1,000M | $1.3B | $1.4B | $1.5B | $1.6B |
| Total liabilities | — | $569M | $576M | $847M | $925M | $1.0B | $1.1B |
| Preferred stock | — | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Shareholders' equity | $148M | $141M | $171M | $256M | $322M | $401M | $468M |
| Margins | |||||||
| Operating margin | 10.2% | 12.6% | 5.6% | 7.0% | 8.2% | 8.2% | 6.0% |
| EBITDA margin | 15.3% | 18.0% | 10.0% | 10.6% | 11.7% | 12.0% | 9.9% |
| Net margin | −2.7% | −1.8% | −2.8% | 1.8% | 2.7% | 4.2% | 2.6% |
| FCF margin | 4.4% | 8.1% | 1.3% | 1.7% | −2.5% | 1.4% | −2.5% |
| Returns | |||||||
| Return on capital | — | 10.1% | 5.3% | 7.0% | 7.7% | 6.8% | 4.4% |
| Return on capital employed | — | 6.8% | 3.2% | 3.4% | 4.3% | 4.3% | 3.1% |
| Return on equity | −8.7% | −5.7% | −9.7% | 5.1% | 6.4% | 8.2% | 4.5% |
| Return on assets | — | −0.9% | −1.6% | 1.0% | 1.4% | 2.0% | 1.2% |
| Return on tangible equity | −8.7% | — | — | — | — | — | — |
| Growth | |||||||
| Revenue growth | — | −5.0% | 17.5% | 9.7% | 15.8% | 4.5% | 3.0% |
| Net income growth | — | — | — | — | 69.8% | 60.2% | −34.5% |
| EPS growth | — | — | — | — | 28.0% | 43.8% | −41.3% |
| FCF growth | — | 73.0% | −81.8% | 46.9% | −274.4% | — | −288.1% |
| Share count change | — | 0.0% | −30.0% | 19.3% | 34.2% | 11.6% | 11.1% |
| Financial health | |||||||
| Net debt / EBITDA | — | 5.2x | 5.2x | 4.4x | 3.9x | 3.7x | 5.6x |
| Debt / equity | — | 3.3x | 1.9x | 1.2x | 1.0x | 0.8x | 0.9x |
| Interest coverage | 1.1x | 1.3x | 0.8x | 1.5x | 2.0x | 2.3x | 1.9x |
| Current ratio | — | 0.8x | 0.9x | 0.8x | 0.4x | 0.4x | 0.3x |
| Quick ratio | — | 0.7x | 0.8x | 0.7x | 0.3x | 0.3x | 0.2x |
| Capital allocation | |||||||
| Capex / revenue | 4.6% | 4.7% | 6.8% | 8.0% | 12.9% | 12.4% | 12.4% |
| Stock comp / revenue | 0.3% | 0.2% | 5.5% | 2.7% | 2.3% | 1.6% | 0.9% |
| Quality scores | |||||||
| Piotroski F-score | — | — | 6.0 | 5.0 | 6.0 | 5.0 | 3.0 |
| Altman Z'' | — | 0.6 | 0.4 | 0.5 | 0.4 | 0.4 | 0.2 |
| Accruals ratio | — | −7.3% | −6.1% | −4.0% | −3.9% | −4.7% | −3.4% |
Source: SEC EDGAR XBRL filings (CIK 0001871509). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only — not investment advice. Check the original filings before relying on any figure.
